Tjeerd Barf
Founder at Acerta Pharma BV
Profile
Tjeerd Barf is the founder and CEO of Artica Therapeutics BV since 2020.
He is also the founder of Acerta Pharma BV.
Currently, he is the Director at Cytura Therapeutics BV since 2019.
Dr. Barf has a graduate and doctorate degree from the University of Groningen.
Tjeerd Barf active positions
| Companies | Position | Start |
|---|---|---|
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Founder | - |
Cytura Therapeutics BV
 Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Director/Board Member | 2019-03-31 |
Artica Therapeutics BV
 Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Artica Therapeutics BV develops covalent therapeutics for autoimmune and inflammatory disorders. The company is based in Leiden, Netherlands. The Dutch company was founded in 2020 by Ad IJzerman, Arwin Ridder, Tjeerd Barf. Tjeerd Barf has been the CEO since 2020. | Founder | 2019-12-31 |
Training of Tjeerd Barf
| University of Groningen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Commercial Services |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Artica Therapeutics BV develops covalent therapeutics for autoimmune and inflammatory disorders. The company is based in Leiden, Netherlands. The Dutch company was founded in 2020 by Ad IJzerman, Arwin Ridder, Tjeerd Barf. Tjeerd Barf has been the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Tjeerd Barf
